Ehrlich Christopher B — SEC Form 4 filings
SEC reporting owner CIK 1293973. 10 Form 4 filings on record with FilingPulse; latest filed 2026-01-09.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-01-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Chairman and CEO, Director | 8 | — | — | 20 |
| eFFECTOR Therapeutics, Inc. (EFTR) | Director | 2 | — | — | 2 |
Form 4 filings — Ehrlich Christopher B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-09 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 4,530,997 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 61,843 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 119,486 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 1,275,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 1,275,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Option exercise (M): 5,312,983 · Option exercise (M): 275 (derivative) @ $1,000 · Disposition to issuer (D): 572,182 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/award (A): 572,182 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Other (J): 1,125,000 · Other (J): 4,171,246 · Other (J): 478,825 · Other (J): 3,600 · Option exercise (M): 0 (derivative) @ $0 · Option exercise (M): 1,555 (derivative) @ $1,000 · +5 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1293973 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →